A recently remeleased rule proposal for Medicare Advantage would give plans greater flexibiilty around the uniformity requirement and allow for the implementation of value-based insurance design principles.
This article was collaboratively written by A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design (V-BID), and several V-BID Center staff.
The Medicare Advantage (MA) uniformity requirement—originally intended to deter discrimination against beneficiaries based on health-status—is often perceived as a barrier to plan innovation.
However, a recently released CMS Medicare Advantage Proposed Rule recommends giving MA plans greater flexibility around the uniformity requirement that will ultimately provide more targeted, “higher-quality and more cost-efficient care” to MA beneficiaries. Such a change would allow for the implementation of value-based insurance design (VBID) principles throughout the MA program.
Proposing Flexibility
The Proposed Rule, in which CMS reinterpret MA uniformity requirements to give MA plans the flexibility “to reduce cost-sharing for certain covered benefits, offer specific tailored supplemental benefits, and offer lower deductibles for enrollees that meet specific medical criteria,” would further shift the MA program from a volume-based to a value-based system and greatly improve the coverage options available to beneficiaries with specified medical conditions (p. 106).
In aligning patients’ out-of-pocket costs, such as copayments and deductibles, with the value of services, VBID plans are designed with the tenets of clinical nuance in mind. These tenants recognize: 1) medical services differ in the amount of health produced, and 2) the clinical benefit derived from a specific service depends on the consumer using it, as well as when, where, and by whom the service is provided.
This nuanced approach to benefit design allows seniors to choose plans that are tailor-made to their unique needs, thereby promoting better health outcomes through the removal of financial barriers to essential care, as well as more efficient health care expenditures by encouraging beneficiaries to utilize high-value services and providers
Highlighting Value in Medicare Advantage
Those already familiar with the MA program may recognize that this is not CMS’ first foray into value-based healthcare provision. Since 2007, CMS has evaluated MA plans based on quality and performance, yielding a star ratings system meant to guide consumer choice.
More recently, in January 2017, CMS launched the MA VBID Model Test. The model, run by the Center for Medicare and Medicaid Innovation (CMMI), allows selected MA plans in designated states to offer varied benefit designs for enrollees diagnosed with specified clinical conditions and is due to expand from 7 to 10 states and add 2 clinical conditions in 2018. With bipartisan, bicameral support to expand the MA VBID Model Test to all 50 states, it is no surprise that CMS is seeking to extend the successes of VBID in the private and public sector to the entirety of the MA program.
The increased adoption of value-based insurance design, coupled with an increased focus on alternative payment models, can improve quality, enhance consumer experience, and lower costs in the MA program.
For more information, view the CMS Medicare Advantage Proposed Rule and visit the Medicare Advantage initiative page on the V-BID Center website.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More